Immunome announced that Purnanand Sarma, PhD, has joined Immunome as President and Chief Executive Officer. Sarma brings more than 25 years of industry experience with a proven track record in drug development, fund raising, and growing companies across multiple R&D platforms ranging from venture-backed biotechnology start-ups to large-cap pharmaceutical companies. Immunome's former Chief Executive Officer, Michael Morin, PhD, assumes the role of Chief Scientific Officer, allowing him to focus his time and expertise on maximizing the value of the company's proprietary breakthrough R&D engine.

Prior to joining Immunome, Sarma was the President & CEO of Taris Biomedical.